A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2003

Study Completion Date

April 30, 2006

Conditions
Osteoarthritis, HipMusculoskeletal Diseases
Interventions
DEVICE

Synvisc (hylan G-F 20)

Trial Locations (32)

10021

Hospital for Special Surgery, New York

15212

Allegheny Orthopedic Associates, Pittsburgh

16635

Altoona Center for Clinical Research, Duncansville

17601

Lancaster Orthopedic Group, Lancaster

21201

Maryland General Hospital, Baltimore

24179

Carilion Bone and Joint Center, Vinton Orthopedic Surgery, Vinton

29526

Conway Medical Center, Conway

31909

Hughston Sports Medicine Foundation, Columbus

33133

Orthopedic Institute at Mercy Hospital, Miami

33756

Orthopedic Specialists of Tamp Bay, P.A., Clearwater

35235

Alabama Clinical Therapeutics, Birmingham

35802

John Higginbotham, MD Sports Medicine, Huntsville

37404

Chattanooga Center for Sports, Chattanooga

40509

Bluegrass Orthopaedics, Lexington

48507

Family Orthopedic Associates, Flint

52403

David S. Tearse, MD (Private Practice), Cedar Rapids

60053

Illinois Bone and Joint Institute, Ltd., Morton Grove

60611

Northwestern Orthopaedic Institute, Chicago

63110

Washington University School of Medicine, St Louis

66211

Kansas City Orthopedic Institute, Leawood

71101

Orthopedic Specialists of Louisiana, Shreveport

72205

Arkansas Orthopaedic Specialists, Little Rock

73109

Health Research Institute, Oklahoma City

79410

Gurdev Gill, MD (Private Practice), Lubbock

83642

Idaho Arthritis & Osteoporosis Center, Meridian

85260

Affiliated Orthopedic Specialists, Scottsdale

90048

Cedars-Sinai Orthopedic Center, Los Angeles

92123

Orthopedic Medical Group, San Diego

94609

Jackson Arthritis Center, Oakland

97527

Orthopedic Center for Joint Replacement & Sports Medicine, Grants Pass

08901

UMDNJ-RWJ University Orthopedic Group, New Brunswick

98166-2967

Arthritis Northwest, Seattle

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00131326 - A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip | Biotech Hunter | Biotech Hunter